Skip to content

Empowered Relief® for Cancer Survivors With Chronic Pain

Feasibility and Preliminary Efficacy of Empowered Relief® for Cancer Survivors With Chronic Pain

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07578376
Enrollment
215
Registered
2026-05-11
Start date
2026-06-01
Completion date
2030-04-30
Last updated
2026-05-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Pain Due to Cancer, Pain Catastrophizing

Keywords

Empowered Relief, Chronic Pain, Cancer survivor, Survey Study, Monthly follow-ups, Zoom class

Brief summary

This randomized controlled study to examine the efficacy of ER class in cancer survivors with chronic pain. Eligible participants will be randomly assigned to a ER class or a waitlist control condition. We will recruit 250 participants with a goal of having 200 completers (20% attrition). Participants in the control condition will be invited to attend ER class after the 3-month observation period.

Detailed description

The Empowered Relief (ER) study is a Zoom-based, 1-session, 2-hour, skills-based pain management class delivered by certified instructors. Participants learn three core pain relief skills, develop a personalized plan, and receive access to a free binaural audio app for daily use and supportive daily text messages. Participants will fill out a series of follow-up surveys at the 1, 2, and 3-month post-class mark. These surveys will be directly compared to surveys given to participants that do not complete the course. Class admittance will be randomized, however, participants not in the treatment group will have the option to take the course after the 3-month observatory period. ER has demonstrated moderate efficacy in individuals with chronic non-cancer pain, reducing pain intensity, pain interference, pain-related distress (pain catastrophizing), sleep disturbance, and anxiety. Because of its brief, didactic nature and delivery via Zoom, ER can accommodate large class sizes and may address access disparities among underserved cancer survivors. ER is currently being studied across various non-cancer populations and has been adopted as standard of care in leading healthcare institutions in the U.S. and abroad. Yet, Empowered Relief has not been tested in cancer survivors.

Interventions

BEHAVIORALEmpowered Relief Course (Zoom)

This is a one-time 2 hour long skills-based pain management class delivered by certified instructors. Participants learn three core pain relief skills, develop a personalized plan, and receive access to a free binaural audio app for daily use and supportive daily text messages.

Sponsors

University of Oklahoma
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 120 Years
Healthy volunteers
No

Inclusion criteria

History of cancer diagnosis, completion of active cancer treatment, cancer free at the time of enrollment, experience of body pain most or every day, pain duration at least 3 months, and English fluency.

Exclusion criteria

Significant psychological and cognitive impairment that limits one's ability to complete study tasks (completion of online survey, attending the zoom-based ER class). Life-threatening acute illness (e.g., infection, heart attack, injury), and no access to a computer, a smartphone or a tablet.

Design outcomes

Primary

MeasureTime frameDescription
Overall treatment satisfactionImmediately after intervention0-10 scale, higher scores indicate greater satisfaction, mean should be 8 or higher

Secondary

MeasureTime frameDescription
Pain Intensity1 month after intervention0-10 scale, higher scores indicate higher pain
Pain Interference1 month after interventionT-scores, higher scores indicate higher pain interference

Countries

United States

Contacts

CONTACTSophia You, PhD, ABPP
Dokyoung-You@ou.edu918-660-3923
CONTACTJordan Keast, BS
jordan-keast@ou.edu
PRINCIPAL_INVESTIGATORSophia You, PhD, ABPP

University of Oklahoma

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: May 15, 2026